Search
forResearch 10 of 96
- Nano-PROTACs: state of the art and perspectives
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- PROTACs: A novel strategy for cancer drug discovery and development
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
Community 2 of 26
- End of Hair loss ( AGA ) ? Since they produce it in china probably we don’t need to wait other 10 yrs😁
- Desensitize Follicle Sensitivity to DHT?
Learn
— no results
Try a deeper search in learn →